{"id":"NCT01720524","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn","officialTitle":"A MULTI-CENTRE, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, TWO-ARMED, PARALLEL GROUP STUDY TO EVALUATE EFFICACY AND SAFETY OF IV SILDENAFIL IN THE TREATMENT OF NEONATES WITH PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN) OR HYPOXIC RESPIRATORY FAILURE AND AT RISK FOR PPHN, WITH A LONG TERM FOLLOW-UP INVESTIGATION OF DEVELOPMENTAL PROGRESS 12 AND 24 MONTHS AFTER COMPLETION OF STUDY TREATMENT","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08-05","primaryCompletion":"2018-10-17","completion":"2020-09-28","firstPosted":"2012-11-02","resultsPosted":"2020-03-25","lastUpdate":"2021-08-16"},"enrollment":59,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Hypertension, Familial Persistent, of the Newborn"],"interventions":[{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"iv sildenafil","otherNames":["revatio"]}],"arms":[{"label":"placebo","type":"PLACEBO_COMPARATOR"},{"label":"sildenafil","type":"EXPERIMENTAL"}],"summary":"This study will evaluate whether IV sildenafil can reduce the time on inhaled nitric oxide treatment and reduce the failure rate of available treatments for persistent pulmonary hypertension of the newborn.","primaryOutcome":{"measure":"Time on Inhaled Nitric Oxide (iNO) Treatment After Initiation of Intravenous (IV) Study Drug For Participants Without Treatment Failure","timeFrame":"14 days from the initiation of IV study drug or hospital discharge, whichever occurs first (maximum of 14 days)","effectByArm":[{"arm":"IV Sildenafil","deltaMin":4.1,"sd":null},{"arm":"Placebo","deltaMin":4.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.9850"}]},"eligibility":{"minAge":"0 Days","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":42,"countries":["United States","Belgium","Canada","Denmark","France","Germany","Italy","Netherlands","Norway","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["34052232"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A1481316&StudyName=A%20Study%20To%20Evaluate%20Safety%20And%20Efficacy%20Of%20IV%20Sildenafil%20In%20The%20Treatment%20Of%20Neonates%20With%20Persistent%20Pulmonary%20Hypertension%20Of%20The%20"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":29},"commonTop":["Hypotension","Anaemia","Hypokalaemia","Pneumothorax","Nasopharyngitis"]}}